Prerna Tewari

576 total citations
24 papers, 280 citations indexed

About

Prerna Tewari is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Prerna Tewari has authored 24 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Prerna Tewari's work include Cervical Cancer and HPV Research (5 papers), Head and Neck Cancer Studies (4 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Prerna Tewari is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Head and Neck Cancer Studies (4 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Prerna Tewari collaborates with scholars based in Ireland, United Kingdom and India. Prerna Tewari's co-authors include Mark Lawler, Paul Browne, Cara Martin, John O’Leary, Patrick Hayden, Derek W. Morris, Lenka Foretová, Anthony Staines, Nikolaus Becker and Alexandra Nieters and has published in prestigious journals such as Human Molecular Genetics, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Prerna Tewari

22 papers receiving 275 citations

Peers

Countries citing papers authored by Prerna Tewari

Since Specialization

Citations

This map shows the geographic impact of Prerna Tewari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prerna Tewari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prerna Tewari more than expected).

Fields of papers citing papers by Prerna Tewari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prerna Tewari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prerna Tewari. The network helps show where Prerna Tewari may publish in the future.

Co-authorship network of co-authors of Prerna Tewari

This figure shows the co-authorship network connecting the top 25 collaborators of Prerna Tewari. A scholar is included among the top collaborators of Prerna Tewari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prerna Tewari. Prerna Tewari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers 2024 ·Scientific Data ·Jessica M. Logan, (unknown), Alexandra Sorvina, I. R. Johnson, Robert D. Brooks, (unknown), (unknown), (unknown), Litsa Karageorgos, Lisa M. Butler, Prerna Tewari, Sarita Prabhakaran, Shane M. Hickey, Sonja Klebe, Hemamali Samaratunga, Brett Delahunt, Kim Moretti, John O’Leary, Doug A. Brooks, Benjamin S.‐Y. Ung	2
2	Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland 2023 ·International Journal of Cancer ·Christine White, (unknown), Katherine C. Murphy, Helen Keegan, (unknown), (unknown), (unknown), (unknown), (unknown), Nóirín Russell, (unknown), Prerna Tewari, Fiona Wright, Sharon O’Toole, Linda Sharp, Grainne Flannelly, John O’Leary, Cara Martin	7
3	Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy 2023 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), Mark P. Ward, Karsten Hokamp, Yanmei Huang, Prerna Tewari, Cara Martin, Lucy Norris, Bashir M. Mohamed, Mark Bates, Robert D. Brooks, Stavros Selemidis, Doug A. Brooks, (unknown), Feras Abu Saadeh, Sharon O’Toole, John O’Leary	7
4	Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread 2023 ·Pathology ·Alexandra Sorvina, (unknown), Sarita Prabhakaran, Jessica M. Logan, Benjamin S.‐Y. Ung, (unknown), I. R. Johnson, Joanna Łaźniewska, Prerna Tewari, (unknown), Robert D. Brooks, Shane M. Hickey, (unknown), Sonja Klebe, Litsa Karageorgos, John O’Leary, Brett Delahunt, Hemamali Samaratunga, Doug A. Brooks	5
5	Development and Validation of a Raman Spectroscopic Classification Model for Cervical Intraepithelial Neoplasia (CIN) 2022 ·Cancers ·Damien Traynor, Shiyamala Duraipandian, Ramya Bhatia, Kate Cuschieri, Prerna Tewari, (unknown), Tom D’Arcy, John O’Leary, Cara Martin, Fiona M. Lyng	9
6	Giant Pleomorphic Adenoma of Parotid Gland: A Rare Cytological Diagnosis 2022 ·JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH ·(unknown), Prerna Tewari, Ruchi Sinha, (unknown)	0
7	Prevalence and concordance of oral HPV infections with cervical HPV infections in women referred to colposcopy with abnormal cytology 2021 ·Journal of Oral Pathology and Medicine ·Prerna Tewari, (unknown), (unknown), (unknown), Christine White, (unknown), Sharon O’Toole, Linda Sharp, Tom D’Arcy, (unknown), Catherine Comiskey, Cara Martin, John O’Leary	6
8	Estimating the conditional probability of developing human papilloma virus related oropharyngeal cancer by combining machine learning and inverse Bayesian modelling 2021 ·PLoS Computational Biology ·Prerna Tewari, (unknown), Cathal Walsh, Cara Martin, Andrew Parnell, John O’Leary	6
9	Carcinoma Breast-Like Giant Complex Fibroadenoma: A Clinical Masquerade 2021 ·Cureus ·Jitendra Singh Nigam, Prerna Tewari, (unknown), Tarun Kumar, (unknown)	1
10	Anorectal Melanoma—Brownish Black Mass Not Always a Hemorrhoid 2021 ·Journal of Gastrointestinal Cancer ·Jitendra Singh Nigam, (unknown), Tarun Kumar, (unknown), Prerna Tewari, (unknown)	1
11	Warthin-Like Variant of Papillary Thyroid Carcinoma: An Uncommon Variant 2020 ·Cureus ·Tarun Kumar, Jitendra Singh Nigam, Prerna Tewari, (unknown)	6
12	Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study 2020 ·Cancer Epidemiology ·Christine White, (unknown), Mark Bates, (unknown), (unknown), Helen Keegan, Sharon O’Toole, Linda Sharp, Ruth O’Kelly, Prerna Tewari, Grainne Flannelly, Cara Martin, John O’Leary	5
13	Ovarian Carcinoid Misinterpreted as Endometrioid Adenocarcinoma in Mature Cystic Teratoma 2020 ·Cureus ·Prerna Tewari, Jitendra Singh Nigam, Tarun Kumar, (unknown), (unknown)	1
14	Clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay in the management of women referred to colposcopy with minor cytological abnormalities 2018 ·Diagnostic Cytopathology ·Prerna Tewari, Christine White, Lynne Kelly, (unknown), Helen Keegan, Tom D’Arcy, Sharon O’Toole, Linda Sharp, John O’Leary, Cara Martin	11
15	Mutational analysis of the insulin‑like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients 2015 ·QUT ePrints (Queensland University of Technology) ·Kathy Gately, (unknown), Steven G. Gray, Derek W. Morris, Aiden Corvin, Prerna Tewari, Kenneth J. O’Byrne	1
16	Multiple myeloma and occupation: A pooled analysis by the International Multiple Myeloma Consortium 2013 ·Cancer Epidemiology ·Carla Perrotta, (unknown), Anthony Staines, Prerna Tewari, Anneclaire J. De Roos, Dalsu Baris, Brenda M. Birmann, Brian C.‐H. Chiu, Wendy Cozen, Nikolaus Becker, Lenka Foretová, Marc Maynadié, Alexandra Nieters, Sílvia de Sanjosé, Lucia Miligi, Adele Seniori Costantini, Mark P. Purdue, John J. Spinelli, Pierluigi Cocco	23
17	PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells 2010 ·British Journal of Cancer ·(unknown), Paul Browne, Patrick Hayden, Elisabeth Vandenberghe, (unknown), Peter Evans, (unknown), Prerna Tewari, Giuseppe Campiani, Stefania Butini, D. Clive Williams, Daniela M. Zisterer, Mark Lawler, (unknown)	27
18	The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers 2009 ·Cancer Biology & Therapy ·Robert W. Foley, Laure Marignol, Arun Z. Thomas, Ivor M. Cullen, (unknown), Prerna Tewari, A O’Grady, E. Kay, B Dunne, Barbara Loftus, R. William G. Watson, J. M. Fitzpatrick, K. Woodson, Teresa A. Lehman, Donal Hollywood, Thomas Lynch, Mark Lawler	45
19	Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time‐points reveals high levels of concordance between molecular and immunophenotypic approaches 2008 ·British Journal of Haematology ·Jacqueline Ryan, Fiona Quinn, (unknown), Ludmila Boublíková, Mireille Crampe, Prerna Tewari, Aengus O’Marcaigh, R.L. Stallings, Michael Neat, A. O’Meara, Fin Breatnach, Shaun R. McCann, Paul Browne, Owen Smith, Mark Lawler	42
20	Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma 2007 ·Human Molecular Genetics ·Patrick Hayden, Prerna Tewari, Derek W. Morris, Anthony Staines, D. Max Crowley, Alexandra Nieters, Nikolaus Becker, Silvia de Sanjosé, Lenka Foretová, Marc Maynadié, Pier Luigi Cocco, Paolo Boffetta, Paul Brennan, Stephen J. Chanock, Paul Browne, Mark Lawler	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact